Tens of thousands of patients with lung cancer in the United Kingdom are missing out on targeted treatment that could improve their prognosis due to delays in genomic testing, a new report has warned.
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of one ...
A 46-year-old man with advanced lung cancer recovered after doctors used Next Generation Sequencing to identify a rare ALK ...
The Independent on MSN
Nine small health issues that could be an early sign of lung cancer
Nine small health issues that could be an early sign of lung cancer - As the NHS offers a ‘revolutionary’ blood test, here ...
Lung Cancer Awareness Month highlights the importance of staying informed about advancements, screening, and preventive ...
The FDA approved the Oncomine Dx Express Test for rapid identification of NSCLC patients eligible for Zegfrovy treatment. The test provides results in 24 hours, aiding timely therapeutic decisions and ...
ATLANTA, Georgia — A combination of gene-expression testing (BronchoGen, Allegro Diagnostics) and diagnostic bronchoscopy significantly improves accuracy in the diagnosis of lung cancer, compared with ...
Ahram Online joined experts in Cairo on 5 December for the ninth International Association for Chest and Lung Tumours (ONTIC) ...
The NLST demonstrated a 20% reduction in lung cancer mortality through annual LDCT screening, leading to its inclusion in clinical guidelines in 2013. However, despite two decades of outreach, only 18 ...
A lung cancer diagnosis can feel frightening. And when a family member is diagnosed, you might wonder about your own risk, prompting you to ask if lung cancer is hereditary. Smoking tobacco accounts ...
GC Genome, a leading clinical genomics and liquid biopsy company, announced that its study analyzing cell-free DNA (cfDNA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback